 Connection
Holly Maples to Humans
This is a "connection" page, showing publications Holly Maples has written about Humans.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.190 |
|
|
|
-
Rybak MJ, Le J, Lodise TP, Levine DP, Bradley JS, Liu C, Mueller BA, Pai MP, Wong-Beringer A, Rodvold KA, Maples HD. Questions on Vancomycin Dosing. Clin Infect Dis. 2021 10 05; 73(7):e1777-e1778.
Score: 0.032
-
Rybak MJ, Le J, Lodise TP, Levine DP, Bradley JS, Liu C, Mueller BA, Pai MP, Beringer AW, Rodvold KA, Maples HD. Validity of 2020 vancomycin consensus recommendations and further guidance for practical application. Am J Health Syst Pharm. 2021 07 22; 78(15):1364-1367.
Score: 0.031
-
Patel K, Crumby AS, Maples HD. Balancing vancomycin efficacy and nephrotoxicity: should we be aiming for trough or AUC/MIC? Paediatr Drugs. 2015 Apr; 17(2):97-103.
Score: 0.020
-
Maples HD, Schutze GE. Consultation with the specialist: malaria prophylaxis in children. Pediatr Rev. 2006 Sep; 27(9):346-50.
Score: 0.011
-
Pough K, Cornaghie M, Rabenhorst B, Maples H, Romero J. Lomentospora prolificans Septic Arthritis and Osteomyelitis in a Pediatric Patient. Pediatr Infect Dis J. 2024 Jun 01; 43(6):e222.
Score: 0.009
-
Maples HD, Stowe CD, Saccente SL, Jacobs RF. Voriconazole serum concentrations in an infant treated for Trichosporon beigelii infection. Pediatr Infect Dis J. 2003 Nov; 22(11):1022-4.
Score: 0.009
-
Haynes AS, Maples H, Parker S. Time for a Change: Considering Vancomycin Alternatives for Pediatric Methicillin-Resistant Staphylococcus aureus Bacteremia. J Pediatric Infect Dis Soc. 2023 May 31; 12(5):308-318.
Score: 0.009
-
Maples HD, James LP, Stowe CD, Jones DP, Hak EB, Blumer JL, Vogt B, Wilson JT, Kearns GL, Wells TG. Famotidine disposition in children and adolescents with chronic renal insufficiency. J Clin Pharmacol. 2003 Jan; 43(1):7-14.
Score: 0.009
-
Lloyd EC, Cogen JD, Maples H, Bell SC, Saiman L. Antimicrobial Stewardship in Cystic Fibrosis. J Pediatric Infect Dis Soc. 2022 Sep 07; 11(Supplement_2):S53-S61.
Score: 0.008
-
Rybak MJ, Le J, Lodise TP, Levine DP, Bradley JS, Liu C, Mueller BA, Pai MP, Wong-Beringer A, Rotschafer JC, Rodvold KA, Maples HD, Lomaestro B. Therapeutic Monitoring of Vancomycin for Serious Methicillin-resistant Staphylococcus aureus Infections: A Revised Consensus Guideline and Review by the American Society of Health-system Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists. Clin Infect Dis. 2020 09 12; 71(6):1361-1364.
Score: 0.007
-
Rybak MJ, Le J, Lodise T, Levine D, Bradley J, Liu C, Mueller B, Pai M, Wong-Beringer A, Rotschafer JC, Rodvold K, Maples HD, Lomaestro BM. Executive Summary: Therapeutic Monitoring of Vancomycin for Serious Methicillin-Resistant Staphylococcus aureus Infections: A Revised Consensus Guideline and Review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists. J Pediatric Infect Dis Soc. 2020 07 13; 9(3):281-284.
Score: 0.007
-
Rybak MJ, Le J, Lodise TP, Levine DP, Bradley JS, Liu C, Mueller BA, Pai MP, Wong-Beringer A, Rotschafer JC, Rodvold KA, Maples HD, Lomaestro BM. Therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections: A revised consensus guideline and review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists. Am J Health Syst Pharm. 2020 05 19; 77(11):835-864.
Score: 0.007
-
Rybak MJ, Le J, Lodise TP, Levine DP, Bradley JS, Liu C, Mueller BA, Pai MP, Wong-Beringer A, Rotschafer JC, Rodvold KA, Maples HD, Lomaestro BM. Executive Summary: Therapeutic Monitoring of Vancomycin for Serious Methicillin-Resistant Staphylococcus aureus Infections: A Revised Consensus Guideline and Review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists. Pharmacotherapy. 2020 04; 40(4):363-367.
Score: 0.007
-
McCaleb R, Warren RH, Willis D, Maples HD, Bai S, O'Brien CE. Description of Respiratory Microbiology of Children With Long-Term Tracheostomies. Respir Care. 2016 Apr; 61(4):447-52.
Score: 0.005
-
Newland JG, Gerber JS, Weissman SJ, Shah SS, Turgeon C, Hedican EB, Thurm C, Hall M, Courter J, Brogan TV, Maples H, Lee BR, Hersh AL. Prevalence and characteristics of antimicrobial stewardship programs at freestanding children's hospitals in the United States. Infect Control Hosp Epidemiol. 2014 Mar; 35(3):265-71.
Score: 0.005
-
Hyun DY, Hersh AL, Namtu K, Palazzi DL, Maples HD, Newland JG, Saiman L. Antimicrobial stewardship in pediatrics: how every pediatrician can be a steward. JAMA Pediatr. 2013 Sep; 167(9):859-66.
Score: 0.005
-
Muldrew KM, Maples HD, Stowe CD, Jacobs RF. Intravenous voriconazole therapy in a preterm infant. Pharmacotherapy. 2005 Jun; 25(6):893-8.
Score: 0.003
-
Jacobs RF, Maples HD, Aranda JV, Espinoza GM, Knirsch C, Chandra R, Fisher JM, Kearns GL. Pharmacokinetics of intravenously administered azithromycin in pediatric patients. Pediatr Infect Dis J. 2005 Jan; 24(1):34-9.
Score: 0.002
-
Roberts GM, Wheeler JG, Tucker NC, Hackler C, Young K, Maples HD, Darville T. Nonadherence with pediatric human immunodeficiency virus therapy as medical neglect. Pediatrics. 2004 Sep; 114(3):e346-53.
Score: 0.002
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|